Skip to content
VJHemOnc Social Logo
  • Registration
  • Programme
  • On-demand
  • VJHemOnc
  • Contact Us
Incyte BoothAdam Barkay2020-10-13T09:51:52+00:00

Disclaimer

This exhibit and its contents are intended to be viewed only by licensed healthcare professionals (HCPs). If you are not a licensed healthcare professional you are not allowed to access the relevant exhibit and you are instructed to return to the main exhibit hall.

This section may contain information about investigational compounds and/or investigational uses of approved products. The safety and efficacy of these investigational compounds or investigational uses of approved products have not been established nor approved.

I AM A HCP
I AM NOT A HCP

Notice

You have asked to access Our “Portfolio” Material.

Yes
No

Notice

You have asked to access Our “Medical Information and Research” Materials.

Yes
No

Notice

You have asked to access Our “CITADEL Program” Material.

Yes
No

Notice

You have asked to access Our “FIRST-MIND Study” Material.

Yes
No

Notice

You have asked to access Our “B-MIND Study” Material.

Yes
No

Discover Our Portfolio

Portfolio chart
Close

Medical Information and Research

Medical Information Request Form
French – Iclusig Approved Label September 2019 – RMP update
English – Iclusig Approved Label September 2019 – RMP update
Targeted Therapy Brochure
Close
Toggle Sliding Bar Area

Twitter Feed

#EHA2021

AvatarLars Klingen Gjærde@larsgjaerde·
22 Oct

Our study on the improved survival and cure rates after allo-#bmt for #ALL in Denmark in the last two decades presented at #EHA2021 is now out in Leukemia & Lymphoma. A population-based study thanks to the collaboration between @Rigshospitalet and @AUHdk http://www.tandfonline.com/eprint/HAS5TFYPEWDDPBUJYWGA/full?target=10.1080/10428194.2021.1992620

Reply on Twitter 1451529513217712130Retweet on Twitter 1451529513217712130Like on Twitter 14515295132177121303Twitter 1451529513217712130
AvatarEuropean Hematology Association@EHA_Hematology·
8 Oct

It's the first live day for the Highlights of Past #EHA (HOPE) Latin America. With tailored #EHA2021 content, this #EHAHOPE is meant for Latin America based professionals in #hematology.
You can still register for free to attend the live sessions.
http://eha.events/HOPE_Register

Reply on Twitter 1446415180972412958Retweet on Twitter 1446415180972412958Like on Twitter 1446415180972412958Twitter 1446415180972412958
AvatarEuropean Hematology Association@EHA_Hematology·
1 Oct

The Highlights of Past #EHA (HOPE) Latin America platform is now open. Organized in concert with regional partners, discover #EHA2021 content on #AML, #CLL, #hemoglobinpathies, #BMF, #multiplemyeloma & more. Register for free:
http://eha.events/HOPE_Register

Reply on Twitter 1443878587367673862Retweet on Twitter 1443878587367673862Like on Twitter 14438785873676738621Twitter 1443878587367673862
AvatarLymphoma Hub@lymphomahub·
26 Sep

👀 During #EHA2021, we spoke with Martin Dreyling, @LMU_Muenchen, about the ELARA trial, and the latest data of tisa-cel for patients with follicular #lymphoma
📽️https://loom.ly/HQi_BjI

Reply on Twitter 1442112237892608012Retweet on Twitter 1442112237892608012Like on Twitter 1442112237892608012Twitter 1442112237892608012
AvatarEuropean Hematology Association@EHA_Hematology·
23 Sep

The Highlights of Past #EHA (HOPE) Middle East & North Africa live days start today. This unique opportunity offers curated #EHA2021 content to professionals in #hematology based in the MENA region.
Not yet registered for #EHAHOPE? Sign up for the event:
http://eha.events/HOPE_Register

Reply on Twitter 1440918936216870913Retweet on Twitter 1440918936216870913Like on Twitter 1440918936216870913Twitter 1440918936216870913
Load More...
Go to Top